Cargando…
Use of Transgenic Animals in Biotechnology: Prospects and Problems
During the past two decades, there have been numerous attempts at using animals in order to produce recombinant human proteins and monoclonal antibodies. However, it is only recently that the first two therapeutic agents isolated from the milk of transgenic animals, C1 inhibitor (Ruconest) and antit...
Autores principales: | Maksimenko, O. G., Deykin, A.V., Khodarovich, Yu. M., Georgiev, P. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612824/ https://www.ncbi.nlm.nih.gov/pubmed/23556129 |
Ejemplares similares
-
An update on the tools for creating transgenic animal models of human diseases – focus on atherosclerosis
por: Volobueva, A.S., et al.
Publicado: (2019) -
Production of Recombinant Proteins in the Milk of Transgenic Animals: Current State and Prospects
por: Shepelev, M. V., et al.
Publicado: (2018) -
The Use of Transcription Terminators to Generate Transgenic Lines of Chinese Hamster Ovary Cells (CHO) with Stable and High Level of Reporter Gene Expression
por: Gasanov, N. B., et al.
Publicado: (2015) -
Animal models of human atherosclerosis: current progress
por: Poznyak, A.V., et al.
Publicado: (2020) -
The use of maize haploidy inducers
as a tool in agricultural plant biotechnology
por: Ulyanov, A.V., et al.
Publicado: (2022)